Table of Content

1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Introduction and Overview
1.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Manufacturer
2.2 Manufacturers Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Area Served, Product Types
2.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Competitive Situation and Trends
2.3.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Sanofi S.A.
3.1.1 Sanofi S.A. Company Profile
3.1.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.1.3 Sanofi S.A. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
3.1.4 Sanofi S.A. Business Overview
3.2 Reckitt Benckiser Group PLC
3.2.1 Reckitt Benckiser Group PLC Company Profile
3.2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.2.3 Reckitt Benckiser Group PLC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
3.2.4 Reckitt Benckiser Group PLC Business Overview
3.3 Pfizer Inc.
3.3.1 Pfizer Inc. Company Profile
3.3.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.3.3 Pfizer Inc. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
3.3.4 Pfizer Inc. Business Overview
3.4 GlaxoSmithKline Plc
3.4.1 GlaxoSmithKline Plc Company Profile
3.4.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.4.3 GlaxoSmithKline Plc Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
3.4.4 GlaxoSmithKline Plc Business Overview
3.5 Sun Pharmaceutical Industries Ltd
3.5.1 Sun Pharmaceutical Industries Ltd Company Profile
3.5.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.5.3 Sun Pharmaceutical Industries Ltd Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
3.5.4 Sun Pharmaceutical Industries Ltd Business Overview
3.6 Assertio Therapeutics, Inc.
3.6.1 Assertio Therapeutics, Inc. Company Profile
3.6.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.6.3 Assertio Therapeutics, Inc. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
3.6.4 Assertio Therapeutics, Inc. Business Overview
3.7 Johnson & Johnson
3.7.1 Johnson & Johnson Company Profile
3.7.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.7.3 Johnson & Johnson Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
3.7.4 Johnson & Johnson Business Overview
3.8 Bayer AG
3.8.1 Bayer AG Company Profile
3.8.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.8.3 Bayer AG Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
3.8.4 Bayer AG Business Overview
3.9 Horizon Therapeutics plc
3.9.1 Horizon Therapeutics plc Company Profile
3.9.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.9.3 Horizon Therapeutics plc Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
3.9.4 Horizon Therapeutics plc Business Overview
3.10 Iroko Pharmaceuticals Inc.
3.10.1 Iroko Pharmaceuticals Inc. Company Profile
3.10.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.10.3 Iroko Pharmaceuticals Inc. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
3.10.4 Iroko Pharmaceuticals Inc. Business Overview
4 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historical and Forecast Market Analysis by Type
4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Type
4.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast by Type (2024-2030)
5 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historical and Forecast Market Analysis by Application
5.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2019-2024)
5.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast by Application (2024-2030)
6 Global Market Growth Trends Analysis
6.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size & Forecast (2019-2030)
6.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends Analysis by Regions
6.2.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions: 2019 VS 2024 VS 2030
6.2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Revenue Market Size by Regions (2019-2024)
6.2.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Revenue Market Size by Regions (2024-2030)
7 North America
7.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Size & Forecast (2019-2030)
7.2 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross and Gross Margin (2019-2024)
7.3 North America PEST Analysis
8 Europe
8.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Size & Forecast (2019-2030)
8.2 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross and Gross Margin (2019-2024)
8.3 Europe PEST Analysis
9 China
9.1 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Size & Forecast (2019-2030)
9.2 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross and Gross Margin (2019-2024)
9.3 China PEST Analysis
10 Japan
10.1 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Size & Forecast (2019-2030)
10.2 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross and Gross Margin (2019-2024)
10.3 Japan PEST Analysis
11 Korea
11.1 Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Size & Forecast (2019-2030)
11.2 Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross and Gross Margin (2019-2024)
11.3 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Size & Forecast (2019-2030)
12.2 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross and Gross Margin (2019-2024)
12.3 Southeast Asia PEST Analysis
13 India
13.1 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Size & Forecast (2019-2030)
13.2 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross and Gross Margin (2019-2024)
13.3 India PEST Analysis
14 South America
14.1 South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Size & Forecast (2019-2030)
14.2 South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross and Gross Margin (2019-2024)
14.3 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Size & Forecast (2019-2030)
15.2 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross and Gross Margin (2019-2024)
15.3 Middle East & Africa PEST Analysis
16 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industrial Chain Analysis
17 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Dynamic Analysis
17.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends Analysis
17.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers Analysis
17.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges Analysis
17.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints Analysis